IP vs RCUS
International Paper (IP) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the IP and RCUS stock pages for the full models.
Not investment advice.